Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of etoricoxib 120 mg vs Arcoxia 120 mg under fasting in healthy Thai volunteers
TCTR20230520001Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etoricoxib in pain and arthritis (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
painarthritis
Beyond the preview
Go deeper on TCTR20230520001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230520001.